Manufacturing Platform
Commercial Manufacturing Platform
Raysun is developing a purpose-built manufacturing platform in Vientiane, Laos, designed to support selected peptide API and sterile drug-product programs. The current engineering phase integrates process layout, classified areas, clean utilities, equipment interfaces, contamination-control strategy and qualification planning.
The platform is planned around dedicated cartridge and lyophilized-vial pathways. Final equipment configuration, operating scale, manufacturing availability and GMP status will be confirmed only after installation, commissioning, qualification, validation and applicable regulatory authorization.
Planned Sterile Manufacturing Lines
| System | Planned Scope | Current Stage |
|---|---|---|
| Cartridge Line | Single- and dual-chamber cartridge filling and assembly using ready-to-use sterile components | Integration Planning |
| Lyophilized-Vial Line | 3 mL, 6 mL and 10 mL vial washing, depyrogenation, aseptic filling, lyophilization and capping | Integration Planning |
| Aseptic Barrier Systems | RABS-supported control of critical filling and product-exposure zones | Design Review |
Facility & Utility Readiness
| Workstream | Planned Scope | Current Stage |
|---|---|---|
| Cleanroom & HVAC | Classified-room zoning, pressure cascades and environmental control | Detailed Design |
| Clean Utilities | Water for injection, clean steam, clean compressed air and high-purity nitrogen | Load Definition |
| Qualification & Validation | Installation, commissioning, qualification, validation and aseptic process simulation | Master Planning |
The facility is under development and is not yet authorized for routine GMP manufacturing. Final capacity, configuration and availability remain subject to documented engineering, qualification and regulatory completion.
Vientiane Site
Integrated Manufacturing Campus
Peptide APIs · Sterile Drug Products · Integrated Development Programs
Completion visualization based on the current site plan. Facility development is in progress.
Planned Manufacturing Scope
Planned Manufacturing Capabilities
Raysun's Vientiane platform is being developed to support selected peptide API and sterile drug-product programs through coordinated process, facility and quality systems. Final manufacturing scope and operating scale will be confirmed after equipment installation, qualification and validation.
- Planned cartridge filling and assembly for single- and dual-chamber presentations
- Planned 3 mL, 6 mL and 10 mL lyophilized-vial manufacturing pathways
- RABS-supported aseptic processing concept for critical product-exposure areas
- Planned integration of washing, depyrogenation, filling, lyophilization and capping
- Multi-product operation supported by segregation, changeover and cleaning-validation strategies
Integrated Support
Program & Service Scope
Available development and project-review services are coordinated with the staged readiness of the Vientiane manufacturing platform.
| Capability Area | Availability | Integrated Support |
|---|---|---|
| Peptide API Programs | Project Review Available | Route development, process optimization, purification, analytical control and manufacturing-readiness planning. |
| Oligonucleotide Programs | Project Review Available | Process development, impurity strategy, analytical support and sterile-formulation feasibility assessment. |
| Growth Hormone API & FDF | Development Support Available | API development, formulation planning, presentation selection and technology-transfer preparation. |
| Sterile Drug Products | Platform Under Development | Formulation, presentation selection, fill-finish design, compatibility and quality-control planning. |
| Analytical & Quality Services | Project-Based Support | Method planning, validation strategy, stability, documentation and release-readiness support. |
| Technology Transfer & Regulatory Support | Project-Based Support | Transfer planning, qualification strategy, regulatory documentation and lifecycle coordination. |
Manufacturing availability and final project scope are confirmed only after technical review and completion of the applicable facility qualification, validation and regulatory requirements.
Regulatory Readiness
Qualification & Regulatory Pathway
The Vientiane project is progressing through a structured engineering, qualification and regulatory-readiness pathway. Routine GMP manufacturing will begin only after documented completion and applicable authorization.
| Stage | Scope | Status |
|---|---|---|
| Civil & Structural Base-Build | Main building structure and foundational site works | Completed |
| Detailed Engineering | Cleanroom layout, HVAC zoning, utilities and equipment interfaces | In Progress |
| Equipment Integration | Equipment manufacture, factory acceptance testing, installation and commissioning | Planned |
| Qualification & Validation | DQ, IQ, OQ, PQ, cleaning validation and aseptic process simulation | Planned |
| GMP Application & Inspection | Regulatory submission, inspection and corrective-action completion where required | Pending |
| Routine GMP Operation | Authorized manufacturing following documented regulatory approval | Not Yet Authorized |
No inspection outcome or GMP approval is claimed before completion of the applicable regulatory process.
Final equipment configuration, capacity, manufacturing scope, operating status and delivery timelines are confirmed only through project-specific technical, quality and regulatory review.